SCHEMBL20012664

SCHEMBL20012664

CCOC(=O)CC(O)[C@@H](C)C1CCC2C3CC[C@@H]4C[C@H](O)CC[C@]4(C)C3C[C@H](O)[C@@]21C

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.62
▸ LMNA P02545 2/20 0.62
▸ MAPK1 P28482 2/20 0.62
▸ MEN1 O00255 1/20 0.62
▸ KMT2A Q03164 1/20 0.62
▸ USP2 O75604 1/20 0.62
▸ GPBAR1 Q8TDU6 11/20 0.60
▸ SLC10A2 Q12908 2/20 0.60
▸ NR1H4 Q96RI1 2/20 0.60
▸ TBXA2R P21731 1/20 0.60
▸ PDE3A Q14432 1/20 0.60
▸ CA1 P00915 3/20 0.52
▸ CA2 P00918 3/20 0.52
▸ ABCC4 O15439 1/20 0.51
▸ CYP2C9 P11712 1/20 0.49
▸ HIF1A Q16665 1/20 0.49
▸ VDR P11473 1/20 0.49
▸ TP53 P04637 1/20 0.47
▸ CASP7 P55210 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20008824 1.00 MAPT (0.62) MAPTLMNAMAPK1MEN1KMT2A
SCHEMBL16225956 0.84 GPBAR1 (0.65) MAPTLMNAMAPK1MEN1KMT2A
SCHEMBL22699678 0.84 MAPT (0.83) MAPTLMNAMAPK1MEN1KMT2A
SCHEMBL4971166 0.84 MAPT (0.83) MAPTLMNAMAPK1MEN1KMT2A
SCHEMBL11646243 0.83 MAPT (0.66) MAPTLMNAMAPK1MEN1KMT2A
SCHEMBL4279489 0.82 GPBAR1 (0.68) MAPTLMNAMAPK1MEN1KMT2A
SCHEMBL4279494 0.82 GPBAR1 (0.68) MAPTLMNAMAPK1MEN1KMT2A
SCHEMBL17090568 0.81 MAPT (0.69) MAPTLMNAMAPK1MEN1KMT2A
SCHEMBL19705475 0.81 GPBAR1 (0.67) MAPTLMNAMAPK1MEN1KMT2A
SCHEMBL20008828 0.81 GPBAR1 (0.67) MAPTLMNAMAPK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11117925-B2 Methods for the preparation of deoxycholic acid, and intermediates useful in the preparation of deoxycholic acid BIONICE, S.L.U. (ES) 2021-09-14 — — US disclosed
US-20180086786-A1 PREPARATION OF DEOXYCHOLIC ACID CRYSTAL PHARMA S.A.U. (ES) 2018-03-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180086786-A1 PREPARATION OF DEOXYCHOLIC ACID SLC10A1, DHCR7, NR1H4 MAPT 2049/4885LMNA 2063/4885MAPK1 2471/4885
US-11117925-B2 Methods for the preparation of deoxycholic acid, and intermediates useful in the preparation of deoxycholic acid DHCR7, CYP46A1, CYP27A1 MAPT 2762/4885LMNA 597/4885MAPK1 1958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback